Blood Collection for Research Related to Certain Diseases Involving Blood Vessels

StatusEnrolling by Invitation
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 328 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Re-verified, no change to tracked fields
  3. Re-verified, no change to tracked fields
  4. Re-verified, no change to tracked fields
  5. Re-verified, no change to tracked fields
Show 45 earlier versionsHide 45 earlier versions
  1. Re-verified, no change to tracked fields
  2. Eligibility criteria expanded, about 1 word
  3. 21 versions Re-verified since Oct 16, 2025, no change to tracked fieldsv301-v321
  4. Study Status, Eligibilityv300
  5. 21 versions Re-verified since Feb 27, 2025, no change to tracked fieldsv279-v299
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The collection of human specimens from both patients and healthy volunteers is necessary for the development of laboratory assays to further basic and clinical research studies. This protocol defines the purposes for which specimens will be collected and establishes general conditions under which sample collection will be performed....
Trial Details
NCT Number NCT00047996
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Sickle Cell Disease
Related terms Anemia, Sickle Cell, Coronary Artery Disease
Enrollment 2,000 participants
Start Date
Updated on ClinicalTrials.gov